The U.S. Court of International Trade May 28 a series of tariffs issued by the Trump administration under the International Emergency Economic Powers Act, a law granting the president authority to regulate various economic transactions following the declaration of a national emergency. The enjoined tariffs include the 10% universal tariffs for all countries and reciprocal tariffs on certain countries with which the U.S. has high trade deficits that were announced April 2. The court order also blocks tariffs imposed on Canada, Mexico and China in February that were based on concerns about illicit fentanyl trafficking. Tariffs imposed under other authorities such as Section 232 tariffs on steel and aluminum imports remain in place and were not impacted by yesterday’s ruling.

The Trump administration immediately filed a in the U.S. Court of Appeals for the Federal Circuit indicating that it will appeal this decision. The appeals court May 29 granted a temporary stay pending the appeal.

A second federal district court May 29 also the Trump administration’s tariffs to be unlawful. The U.S. District Court for the District of Columbia held that IEEPA does not address tariffs at all and therefore does not grant the president the authority to impose such levies. The court issued a preliminary injunction against all tariffs imposed under the IEEPA. The administration is also expected to appeal this decision.

Related News Articles

Chairperson's File
Public
We are all closely watching changing tariff policy as it raises serious considerations for the medical products, devices and pharmaceuticals supply chain. Our…
Chairperson's File
Public
Most hospitals and health systems are the largest organizations in our communities, providing critical services needed by every one of our neighbors. We take…
Headline
The AHA May 16 urged the Department of Commerce to consider tariff exceptions for critical minerals and derivative products used for medical purposes. Critical…
Headline
The AHA May 14 urged the Senate Finance Committee to take steps to strengthen the supply chain for essential pharmaceutical and other medical products. In…
Headline
The U.S. and China reached a joint agreement to temporarily reduce tariffs for 90 days, the White House announced May 12. Both countries will lower tariffs by…
Headline
AHA today submitted comments to the Department of Commerce on its Section 232 national security investigation of pharmaceutical and pharmaceutical ingredients…